Lin, Shu-ManShu-ManLinLiu, Peter Pin-SungPeter Pin-SungLiuYU-KANG TULai, Edward Chia-ChengEdward Chia-ChengLaiYeh, Jih-IJih-IYehHsu, Jin-YiJin-YiHsuMunir, Kashif MKashif MMunirPeng, Carol Chiung-HuiCarol Chiung-HuiPengHuang, Huei-KaiHuei-KaiHuangLoh, Ching-HuiChing-HuiLoh2023-02-172023-02-172023-01-061475-2840https://scholars.lib.ntu.edu.tw/handle/123456789/628374Heart failure (HF) is a critical complication in elderly patients with atrial fibrillation (AF) and diabetes mellitus (DM). Recent preclinical studies suggested that non-vitamin K antagonist oral anticoagulants (NOACs) can potentially suppress the progression of cardiac fibrosis and ischemic cardiomyopathy. Whether different oral anticoagulants influence the risk of HF in older adults with AF and DM is unknown. This study aimed to evaluate the risk of HF in elderly patients with AF and DM who were administered NOACs or warfarin.enAtrial fibrillation; Diabetes mellitus; Elderly; Heart failure; Oral anticoagulant[SDGs]SDG3journal article10.1186/s12933-022-01688-1366093172-s2.0-85145870180WOS:000910111300001https://api.elsevier.com/content/abstract/scopus_id/85145870180